VERONICA CHANG: Open Payments
NPI 1346524691 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,323 in 209 payments from 24 companies in 2025. Trend: 2023 $2,086 · 2024 $3,161 · 2025 $4,323
Food & beverage: $4,223Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $519 |
| Arcutis Biotherapeutics, Inc. | 19 | $408 |
| UCB, Inc. | 31 | $405 |
| LEO Pharma Inc. | 19 | $386 |
| GENZYME CORPORATION | 9 | $348 |
| Regeneron Healthcare Solutions, Inc. | 8 | $324 |
| Galderma Laboratories, L.P. | 19 | $321 |
| Incyte Corporation | 15 | $290 |
| PFIZER INC. | 15 | $225 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $165 |
Products named: DUPIXENT, Zoryve, Bimzelx, ADBRY, SKYRIZI, OPZELURA, CIBINQO, RINVOQ.
Industry payments across CA — which companies pay providers there.
